86 Results

People

  1. Abdel-Wahab
    Abdel-Wahab
  2. Diamond
    Diamond
  3. Hyman
    Hyman
  4. Rampal
    Rampal
  5. Rosen
    Rosen
  6. Durham
    Durham
  7. Chung
    Chung
  8. Solit
    Solit
  9. Kim
    Kim
  10. Merghoub
    Merghoub

Groups

  1. Center for Hematologic Malignancies (86)
  2. Department of Medicine (86)
  3. Executive Committee, Center for Hematologic Malignancies (86)
  4. GSK Faculty (86)
  5. Hematologic Malignancies, Division of (86)
  6. Human Oncology and Pathogenesis Program (86)
  7. Solid Tumor Oncology Division (86)
  8. Tow Center for Developmental Oncology (TCDO) (86)
  9. Sloan Kettering Institute Postdocs (50)
  10. Adult Leukemia (44)
  1. "Omar Abdel-Wahab"
  2. "Solid Tumor Oncology Division"
Formats
  1. Meeting Abstract (43)
  2. Journal Article (42)
  3. Book Section (1)
Groups
  1. Center for Hematologic Malignancies (86)
  2. Department of Medicine (86)
  3. Executive Committee, Center for Hematologic Malignancies (86)
  4. GSK Faculty (86)
  5. Hematologic Malignancies, Division of (86)
  6. Human Oncology and Pathogenesis Program (86)

More Groups

People
  1. Omar Abdel-Wahab (86)
  2. Eli Diamond (37)
  3. David Hyman (34)
  4. Raajit Rampal (33)
  5. Benjamin Durham (30)
  6. Neal Rosen (24)

More People

Years
  1. 2023 (3)
  2. 2022 (6)
  3. 2021 (6)
  4. 2020 (6)
  5. 2019 (8)
  6. 2018 (10)

More Years

Publications
  1. Blood (19)
  2. Cancer Discovery (6)
  3. Cancer Research (6)
  4. Pediatric Blood and Cancer (6)
  5. Journal for ImmunoTherapy of Cancer (3)
  6. Journal of Clinical Investigation (3)

More Publications

Publishers
  1. American Society of Hematology (21)
  2. American Association for Cancer Research (14)
  3. Nature Publishing Group (8)
  4. Wiley Periodicals, Inc (6)
  5. Cell Press (5)
  6. Biomed Central Ltd (4)

More Publishers

Results (86)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms is countered by heteroclitic peptide cancer vaccination
    Meeting Abstract

    Gigoux, M.; Zappasodi, R.; Park, J.; Bozkus, C. C.; Mangarin, L.; Redmond, D.; Verma, S.; Schad, S.; George, M.; Venkatesh, D.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: A multicentre, single-arm, phase 2 trial
    Journal Article

    Soumerai, J. D.; Mato, A. R.; Dogan, A.; Seshan, V. E.; Joffe, E.; Flaherty, K.; Carter, J.; Hochberg, E.; Barnes, J. A.; Hamilton, A. M.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • Pharmacologic modulation of RNA splicing enhances anti-tumor immunity
    Journal Article

    Lu, S. X.; De Neef, E.; Thomas, J. D.; Sabio, E.; Rousseau, B.; Gigoux, M.; Knorr, D. A.; Greenbaum, B.; Elhanati, Y.; Hogg, S. J.; more...
    Cell (2021)

    Fulltext@MSK | Save
  • ARAF activates RAS by antagonizing its binding to the RASGAP NF1
    Meeting Abstract

    Yao, Z.; Su, W.; Yaeger, R.; Son, J.; Adachi, Y.; Han, S. W.; Taylor, B. S.; Ebi, H.; Abdel-Wahab, O.; de Stanchina, E.; more...
    Cancer Science (2021)

    Fulltext@MSK | Save
  • Mutant SF3B1 promotes AKT- and NF-κB-driven mammary tumorigenesis
    Journal Article

    Liu, B.; Liu, Z.; Chen, S.; Ki, M.; Erickson, C.; Reis-Filho, J. S.; Durham, B. H.; Chang, Q.; de Stanchina, E.; Sun, Y.; more...
    Journal of Clinical Investigation (2021)

    Fulltext@MSK | Save
  • MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms is countered by heteroclitic peptide cancer vaccination
    Meeting Abstract

    Gigoux, M.; Zappasodi, R.; Park, J.; Pourpe, S.; Ghosh, A.; Bozkus, C. C.; Mangarin, L.; Redmond, D.; Verma, S.; Schad, S.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Heteroclitic peptide cancer vaccine counters MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms
    Meeting Abstract

    Gigoux, M.; Zappasodi, R.; Park, J. J.; Pourpe, S.; Ghosh, A.; Bozkus, C. C.; Mangarin, L. M. B.; Redmond, D.; Verma, S.; Schad, S.; more...
    Journal of Immunology (2020)

    Fulltext@MSK | Save
  • Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor
    Journal Article

    Taylor, J.; Donoghue, M. T. A.; Ho, C.; Petrova-Drus, K.; Al-Ahmadie, H. A.; Funt, S. A.; Zhang, Y.; Aypar, U.; Rao, P.; Chavan, S. S.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save
  • Leveraging systematic functional analysis to benchmark an in silico framework distinguishes driver from passenger MEK mutants in cancer
    Journal Article

    Hanrahan, A. J.; Sylvester, B. E.; Chang, M. T.; Elzein, A.; Gao, J.; Han, W.; Liu, Y.; Xu, D.; Gao, S. P.; Gorelick, A. N.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Neurologic and oncologic features of Erdheim-Chester disease: A 30-patient series
    Journal Article

    Bhatia, A.; Hatzoglou, V.; Ulaner, G.; Rampal, R.; Hyman, D. M.; Abdel-Wahab, O.; Durham, B. H.; Dogan, A.; Ozkaya, N.; Yabe, M.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save